Summary

Report Scope
The report provides an overview of the global topical drug delivery market and analyzes market trends. It includes global revenue ($ Billion) for the base year of 2025 and estimated revenue for the forecast period of 2026 through 2031. The market is segmented by product type, drug class, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on the major countries in each region.
The report focuses on the key driving trends and challenges shaping the market and vendor landscape.
The report concludes with an analysis of the competitive landscape, which provides market shares for key participants in the global topical drug delivery market. It also includes a dedicated section of company profiles that covers details of leading companies in the market.
Report Includes
- 63 data tables and 55 additional tables
- An overview and analysis of the global topical drug delivery market
- Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
- Estimates of the current market size and growth prospects, with a market share analysis by product type, drug class, route of administration, end user, and region
- Facts and figures related to market dynamics, including key drivers, restraints, challenges, and opportunities
- Review of macroeconomic factors, U.S. tariff impacts, and insights derived from Porter's Five Forces analysis
- Overview of the regulatory landscape affecting topical drug delivery products across major regions
- Discussion of emerging technologies and developments, including advanced formulations, transdermal systems, and novel delivery approaches
- Patent review and analysis of recent developments related to topical drug delivery technologies
- Analysis of the competitive landscape, including market share rankings, strategic initiatives, and venture funding activity
- Company profiles of major players within the industry, including Galderma, Kenvue, Bayer AG, Haleon, and AbbVie Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Prevalence of Skin Diseases
Growing Patient Preference for Painless Treatments
Chronic Disease Management and Aging Population
Growth in Pharmaceutical R&D
Market Restraints
Limited Skin Permeability
Skin Irritation and Allergic Reactions
High Development Costs for Advanced Formulations
Regulatory and Approval Challenges
Market Opportunities
Emerging Economies
Technological Advances in Drug Delivery
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologiesand Developments
Key Takeaways
Microneedle-Based Drug Delivery
Nanoparticle-Based Drug Delivery Systems
Smart Transdermal Patches and Wearable Systems
3D-Printed Drug Delivery Systems
Stimuli-Responsive and Controlled-Release Systems
Artificial Intelligence (AI) in Topical Drug Delivery
Patent Analysis
Key Findings
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Semi-Solid Formulations
Liquid Formulations
Transdermal Patches
Solid Formulations
Market Analysis by Drug Class
Key Takeaways
Corticosteroids
Anti-inflammatories
Anti-infectives
Analgesics
Others
Market Analysis by End User
Key Takeaways
Home Care Settings
Hospitals and Clinics
Burn Care Centers
Others
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Acquisitions
Partnership and Collaborations
Product Launches/Approvals
Chapter 8 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABBVIE INC.
ALMIRALL
BAUSCH HEALTH COMPANIES INC.
BAYER AG
GALDERMA
GLENMARK PHARMACEUTICALS LTD.
GSK PLC
HALEON PLC
HISAMITSU PHARMACEUTICAL CO. INC.
JOHNSON & JOHNSON SERVICES INC.
KENVUE
LEO PHARMA A/S
SANOFI
SOLVENTUM
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Few Emerging Startups/Market Disruptors

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Topical Drug Delivery, by Region, Through 2031
Table 1 : Topical Drug Delivery Intended for Several Skin Diseases
Table 2 : World Economic Outlook Projections, 2024-2026
Table 3 : Chronic Conditions in 2024
Table 4 : Predicted GDP Growth Rates, by Region, 2026
Table 5 : Patent Shares for Topical Drug Delivery, by Jurisdiction, 2025
Table 6 : Global Market for Topical Drug Delivery, by Product Type, Through 2031
Table 7 : Global Market for Semi-Solid Formulations in Topical Drug Delivery, by Region, Through 2031
Table 8 : Global Market for Liquid Formulations in Topical Drug Delivery, by Region, Through 2031
Table 9 : Global Market for Transdermal Patches in Topical Drug Delivery, by Region, Through 2031
Table 10 : Global Market for Solid Formulations in Topical Drug Delivery, by Region,Through 2031
Table 11 : Global Market for Topical Drug Delivery, by Drug Class, Through 2031
Table 12 : Global Market for Corticosteroids in Topical Drug Delivery, by Region,Through 2031
Table 13 : Global Market for Anti-inflammatories in Topical Drug Delivery, by Region, Through 2031
Table 14 : Global Market for Anti-infectives in Topical Drug Delivery, by Region,Through 2031
Table 15 : Global Market for Analgesics in Topical Drug Delivery, by Region, Through 2031
Table 16 : Global Market for Other Drug Classes in the Topical Drug Delivery, by Region, Through 2031
Table 17 : Global Market for Topical Drug Delivery, by End User, Through 2031
Table 18 : Global Market for Topical Drug Delivery for Home Care Settings, by Region, Through 2031
Table 19 : Examples of Diseases Treated with Topical Therapies in Hospitals
Table 20 : Global Market for Topical Drug Delivery for Hospitals and Clinics, by Region, Through 2031
Table 21 : Global Market for Topical Drug Delivery for Burn Care Centers, by Region, Through 2031
Table 22 : Global Market for Topical Drug Delivery for Other End Users, by Region,Through 2031
Table 23 : Global Market for Topical Drug Delivery, by Region, Through 2031
Table 24 : North American Market for Topical Drug Delivery, by Product Type, Through 2031
Table 25 : North American Market for Topical Drug Delivery, by Drug Class, Through 2031
Table 26 : North American Market for Topical Drug Delivery, by End User, Through 2031
Table 27 : North American Market for Topical Drug Delivery, by Country, Through 2031
Table 28 : U.S. Market for Topical Drug Delivery, by Product Type, Through 2031
Table 29 : Canadian Market for Topical Drug Delivery, by Product Type, Through 2031
Table 30 : Mexican Market for Topical Drug Delivery, by Product Type, Through 2031
Table 31 : European Market for Topical Drug Delivery, by Product Type, Through 2031
Table 32 : European Market for Topical Drug Delivery, by Drug Class, Through 2031
Table 33 : European Market for Topical Drug Delivery, by End User, Through 2031
Table 34 : European Market for Topical Drug Delivery, by Country, Through 2031
Table 35 : German Market for Topical Drug Delivery, by Product Type, Through 2031
Table 36 : U.K. Market for Topical Drug Delivery, by Product Type, Through 2031
Table 37 : French Market for Topical Drug Delivery, by Product Type, Through 2031
Table 38 : Italian Market for Topical Drug Delivery, by Product Type, Through 2031
Table 39 : Spanish Market for Topical Drug Delivery, by Product Type, Through 2031
Table 40 : Rest of Europe Market for Topical Drug Delivery, by Product Type, Through 2031
Table 41 : Asia-Pacific Market for Topical Drug Delivery, by Product Type, Through 2031
Table 42 : Asia-Pacific Market for Topical Drug Delivery, by Drug Class, Through 2031
Table 43 : Asia-Pacific Market for Topical Drug Delivery, by End User, Through 2031
Table 44 : Asia-Pacific Market for Topical Drug Delivery, by Country, Through 2031
Table 45 : Chinese Market for Topical Drug Delivery, by Product Type, Through 2031
Table 46 : Japanese Market for Topical Drug Delivery, by Product Type, Through 2031
Table 47 : Indian Market for Topical Drug Delivery, by Product Type, Through 2031
Table 48 : South Korean Market for Topical Drug Delivery, by Product Type, Through 2031
Table 49 : Australian Market for Topical Drug Delivery, by Product Type, Through 2031
Table 50 : Rest of Asia-Pacific Market for Topical Drug Delivery, by Product Type, Through 2031
Table 51 : Rest of the World Market for Topical Drug Delivery, by Product Type, Through 2031
Table 52 : Rest of the World Market for Topical Drug Delivery, by Drug Class, Through 2031
Table 53 : Rest of the World Market for Topical Drug Delivery, by End User, Through 2031
Table 54 : Global Ranking of Companies in the Topical Drug Delivery Market, 2025
Table 55 : Acquisitions in Global Topical Drug Delivery Market, 2024–2025
Table 56 : Collaborations in Global Topical Drug Delivery Market, 2023–2026
Table 57 : Product Launches/Approval in Global Topical Drug Delivery Market, 2023–2026
Table 58 : Information Sources Used for this Report
Table 59 : Abbreviations Used in this Report
Table 60 : AbbVie Inc.: Company Snapshot
Table 61 : AbbVie Inc.: Financial Performance, FY 2024 and 2025
Table 62 : AbbVie Inc.: Product Portfolio
Table 63 : AbbVie Inc.: News/Key Developments, 2025
Table 64 : Almirall : Company Snapshot
Table 65 : Almirall : Financial Performance, FY 2024 and 2025
Table 66 : Almirall : Product Portfolio
Table 67 : Almirall : News/Key Developments, 2024–2025
Table 68 : Bausch Health Companies Inc.: Company Snapshot
Table 69 : Bausch Health Companies Inc.: Financial Performance, FY 2024 and 2025
Table 70 : Bausch Health Companies Inc.: Product Portfolio
Table 71 : Bausch Health Companies Inc.: News/Key Developments, 2023–2025
Table 72 : Bayer AG: Company Snapshot
Table 73 : Bayer AG.: Financial Performance, FY 2024 and 2025
Table 74 : Bayer AG: Product Portfolio
Table 75 : Bayer AG: News/Key Developments, 2023–2026
Table 76 : Galderma: Company Snapshot
Table 77 : Galderma: Financial Performance, FY 2024 and 2025
Table 78 : Galderma: Product Portfolio
Table 79 : Galderma: News/Key Developments, 2023–2025
Table 80 : Glenmark Pharmaceuticals Ltd.: Company Snapshot
Table 81 : Glenmark Pharmaceuticals Ltd.: Financial Performance, FY 2023 and 2024
Table 82 : Glenmark Pharmaceuticals Ltd.: Product Portfolio
Table 83 : Glenmark Pharmaceuticals Ltd.: News/Key Developments, 2023–2025
Table 84 : GSK plc: Company Snapshot
Table 85 : GSK plc: Financial Performance, FY 2024 and 2025
Table 86 : GSK plc: Product Portfolio
Table 87 : Haleon plc: Company Snapshot
Table 88 : Haleon plc: Financial Performance, FY 2024 and 2025
Table 89 : Haleon plc: Product Portfolio
Table 90 : Haleon plc: News/Key Developments, 2025
Table 91 : Hisamitsu Pharmaceutical Co. Inc.: Company Snapshot
Table 92 : Hisamitsu Pharmaceutical Co. Inc.: Financial Performance, FY 2023 and 2024
Table 93 : Hisamitsu Pharmaceutical Co. Inc.: Product Portfolio
Table 94 : Hisamitsu Pharmaceutical Co. Inc.: News/Key Developments, 2023–2025
Table 95 : Johnson & Johnson Services Inc.: Company Snapshot
Table 96 : Johnson & Johnson Services Inc.: Financial Performance, FY 2024 and 2025
Table 97 : Johnson & Johnson Services Inc.: Product Portfolio
Table 98 : Johnson & Johnson Services Inc.: News/Key Developments, 2025–2026
Table 99 : Kenvue: Company Snapshot
Table 100 : Kenvue: Financial Performance, FY 2024 and 2025
Table 101 : Kenvue: Product Portfolio
Table 102 : Kenvue: News/Key Developments, 2024–2026
Table 103 : LEO Pharma A/S: Company Snapshot
Table 104 : LEO Pharma A/S: Financial Performance, FY 2024 and 2025
Table 105 : LEO Pharma A/S: Product Portfolio
Table 106 : LEO Pharma A/S: News/Key Developments, 2023-2025
Table 107 : Sanofi: Company Snapshot
Table 108 : Sanofi: Financial Performance, FY 2024 and 2025
Table 109 : Sanofi: Product Portfolio
Table 110 : Sanofi: News/Key Developments, 2025
Table 111 : Solventum: Company Snapshot
Table 112 : Solventum: Financial Performance, FY 2024 and 2025
Table 113 : Solventum: Product Portfolio
Table 114 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 115 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2024 and 2025
Table 116 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 117 : List of a Few Emerging Startups/Market Disruptors

List of Figures
Summary Figure : Summary Figure: Global Market Shares for Topical Drug Delivery, by Region, 2025
Figure 1 : Porter’s Five Forces Analysis of the Topical Drug Delivery Market
Figure 2 : Market Dynamics of Global Topical Drug Delivery
Figure 3 : Number of Patents for Topical Drug Delivery, by Leading Applicants in 2025
Figure 4 : Patent Shares for Topical Drug Delivery, by Document Type, 2025
Figure 5 : Global Market Shares for Topical Drug Delivery, by Product Type, 2025
Figure 6 : Global Market Shares for Topical Drug Delivery, by Drug Class, 2025
Figure 7 : Global Market Shares for Topical Drug Delivery, by End User, 2025
Figure 8 : Global Market Shares for Topical Drug Delivery, by Region, 2025
Figure 9 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 10 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 11 : Almirall : Revenue Shares, by Country/Region, FY 2025
Figure 12 : Bausch Health Companies Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 13 : Bausch Health Companies Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 14 : Bayer AG: Revenue Shares, by Business Unit, FY 2025
Figure 15 : Bayer AG: Revenue Shares, by Country/Region, FY 2025
Figure 16 : GALDERMA: Revenue Shares, by Country/Region, FY 2025
Figure 17 : Glenmark Pharmaceuticals Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 18 : GSK plc: Revenue Shares, by Business Unit, FY 2025
Figure 19 : GSK plc: Revenue Shares, by Country/Region, FY 2025
Figure 20 : Haleon plc: Revenue Shares, by Business Unit, FY 2025
Figure 21 : Haleon plc: Revenue Shares, by Country/Region, FY 2025
Figure 22 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 23 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 24 : KENVUE: Revenue Shares, by Business Unit, FY 2025
Figure 25 : KENVUE: Revenue Shares, by Country/Region, FY 2025
Figure 26 : LEO Pharma A/S: Revenue Shares, by Business Unit, FY 2025
Figure 27 : LEO Pharma A/S: Revenue Shares, by Country/Region, FY 2025
Figure 28 : SANOFI: Revenue Shares, by Country/Region, FY 2025
Figure 29 : SOLVENTUM: Revenue Shares, by Business Unit, FY 2025
Figure 30 : SOLVENTUM: Revenue Shares, by Country/Region, FY 2025
Figure 31 : Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Country/Region, FY 2025